Language
English
Publication Date
6-1-2025
Journal
Pharmacological Research - Natural Products
DOI
10.1016/j.prenap.2025.100236
PMID
42221531
PMCID
PMC13218733
PubMedCentral® Posted Date
5-29-2026
PubMedCentral® Full Text Version
Author MSS
Abstract
Bladder cancer accounts for 4 % of cancer diagnoses in the US. Current treatments primarily involve trans-urethral resection of bladder tumors (TURBT) and immunotherapy with Bacille Calmette-Guerin (BCG). Despite the efficacy of TURBT, issues with residual tumors persist. We chose to utilize Cell Painting to screen a set of 244 flavonoid compounds for bladder cancer cell toxicity. Using multiparametric high content analysis termed SPACe, we discover promising candidates underscoring the potential of flavonoids in targeting bladder cancer cells and elucidating their mechanisms of action. Notably, compounds such as xanthohumol show promise in reducing cancer cell viability by altering lipid metabolism. We further show the effectiveness of hit compounds in subsequent spheroid and chorioallantoic membrane systems. Overall, this research emphasizes the role of innovative screening methods in drug discovery and potential synergistic effects of combining flavonoids with existing therapies like BCG for improved bladder cancer treatment outcomes.
Keywords
Cell Paint, Phenotypic screening, Bladder cancer, Xanthohumol
Published Open-Access
yes
Recommended Citation
Bolt, Michael J; Oceguera, Jessica; Tostado, Alejandra Rivera; et al., "A Phenotypic Screen Identifies Xanthohumol and Other Flavonoids As Killers of Bladder Cancer" (2025). Faculty, Staff and Students Publications. 7065.
https://digitalcommons.library.tmc.edu/baylor_docs/7065